Inflammatory Mechanisms Underlying Metabolic Syndrome-associated Osteoarthritis and Potential Treatments
The exploration of the relationship between metabolic syndrome and OA could benefit the development of targeting strategies for MetS-OA, including currently FDA-approved drugs for the treatment of metabolic syndrome and potential drugs targeting metabolic factors, which might provide a novel avenue for the future management of MetS-OA.
Authors
- Changhai Ding (ORCID: https://orcid.org/0000-0002-9479-730X)
- Zhaohua Zhu (ORCID: https://orcid.org/0000-0003-3913-2564)
- Hao Zhang
- Song Xue (ORCID: https://orcid.org/0000-0002-2932-5488)
- Wenjing Wu
- J. Chen
- Shunqiang Huang
Institutions
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
- Zhujiang Hospital (CN)
- Peking University Shenzhen Hospital (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Osteoarthritis and Cartilage Open
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1016/j.ocarto.2025.100614
- Citations
- 8
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 10.83